NCT06930326Completed
Exosome Treatment and Hair Growth
A Prospective, Randomized, Triple-blind Comparative Study of Exosome and Exosomes-containing Formulation Versus Placebo in Treating Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- COSMEDICIAN AP SDN BHD
- Participants (registry)
- 24
- Start
- November 2022
- Primary completion
- April 2023
- Study completion
- June 2023
- Last registry update
- April 2025
- Countries
- Malaysia
Conditions studied: Alopecia Androgenica
Interventions: intradermal exosome, 0.9 % NaCl
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.